查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929596

疝氣修補器市場按類型、材料類型、產品類型、應用、最終用戶、分銷管道分類，全球預測（2026-2032年）

Hernia Tacker Market by Type, Material Type, Product Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年疝氣固定器市場價值為 1.6221 億美元，預計到 2026 年將成長至 1.7727 億美元，預計到 2032 年將達到 2.5284 億美元，複合年成長率為 6.54%。

關鍵市場統計數據
基準年 2025 1.6221億美元
預計年份：2026年 1.7727億美元
預測年份 2032 2.5284億美元
複合年成長率 (%) 6.54%

本文簡要概述了疝氣修補器在現代外科環境中的臨床效用、採購考量和策略意義。

外科固定器械的演進需要高層進行全面考量，平衡並整合臨床效用、採購實際情況和供應鏈韌性。本文概述了疝釘的現狀，重點介紹了疝釘在現代疝氣修補術流程中的作用、其應用的手術場景，以及臨床結果與器械人體工學和材質選擇之間的關係。深入分析後可知，疝釘並非單一用途、一刀切的器械，而是可配置的工具，其材質成分、一次性使用方式以及與微創技術的兼容性各不相同。

臨床實務、材料和採購方式的快速變化正在重塑手術團隊和供應商對器械性能和長期療效的優先排序。

疝氣修補器領域正經歷一場變革，其驅動力來自不斷發展的臨床實踐、材料科學的進步以及醫療服務模式的轉變。過去幾年，微創技術和加速復健通訊協定的普及推動了對能夠簡化固定流程、縮短手術時間和減少術後併發症的器械的需求。同時，聚合物配方和鈦合金的創新也拓展了設計選擇，使得更輕、生物相容性更好的固定元件成為可能，從而滿足了外科醫生的人體工學偏好。

2025年關稅趨勢的變化正在重塑外科器械相關人員的籌資策略，加劇了對供應鏈韌性的需求。

2025年關稅調整和貿易政策發展的累積影響，為製造商、經銷商和醫療系統採購團隊帶來了額外的營運複雜性。關稅結構的變化將影響原料的採購選擇，尤其是含有鈦等高價值金屬和特殊醫用級聚合物的醫療設備。因此，供應鏈負責人必須在成本壓力與確保器材品質穩定和符合監管要求的臨床需求之間取得平衡。

以細分市場主導的洞察，將臨床應用案例、產品形式、通路和材料選擇與可操作的商業化選擇聯繫起來。

對市場區隔的深入理解能夠指導產品設計、市場進入策略和臨床合作策略。按應用領域分類，我們檢視切口疝氣、腹股溝疝氣、臍疝氣和腹疝氣。每種應用領域都有其自身的固定挑戰和臨床優先事項，這些因素會影響器械的選擇和外科醫生的偏好。依產品類型分類，我們分析一次性器械和可重複使用器械的市場，並根據單位經濟效益、消毒基礎設施和感染控制通訊協定，建構不同的價值提案。按最終用戶分類，我們分析門診手術中心、診所和醫院的市場。各機構的手術量、採購權限及醫療服務模式的差異會影響器材的採用路徑和物流。

採購、臨床實踐和基礎設施的區域差異決定了世界各地採取不同的策略方法。

區域趨勢影響著監管路徑、採購行為和臨床實踐模式，為醫療設備製造商和供應商帶來不同的機會和挑戰。美洲市場通常高度重視高效的採購週期、門診手術中心的高利用率以及能夠縮短手術時間和減少術後併發症的證據。歐洲、中東和非洲地區的法規結構和醫院採購流程各不相同，因此在地化的臨床數據和有針對性的報銷策略顯得尤為重要。在亞太地區，微創技術的快速普及與醫院基礎設施的多樣性並存，根據該地區的臨床經濟狀況，既需要經濟實惠的一次性產品，也需要耐用的可重複使用系統。

競爭分析應著重於臨床支援、產品差異化和通路效率，以此作為永續優勢的來源。

疝氣修補器材領域的競爭動態由臨床證據、技術差異化和商業性可行性三者共同驅動。主要企業憑藉器材的人體工學設計、材料科學以及對外科團隊的臨床支援等優勢展開競爭。有些企業強調一次性使用的便利性，以滿足感染控制和手術量的需求；而有些企業則專注於可重複使用的平台，以最大限度地降低高流量中心的單例手術成本。此外，外科醫生培訓計畫、手術記錄和快速分銷網路等配套服務也常常帶來競爭優勢。

實際可行的策略性舉措，旨在經營團隊主管提高醫療設備產品組合的臨床應用率、增強供應鏈韌性並實現價值驅動的商業化。

產業領導者應優先採取一系列戰術性和策略舉措，將洞察轉化為可衡量的成果。首先，根據每項手術的具體需求（例如切口、鼠蹊部、臍部和腹壁修復），將材料和產品類型的選擇與臨床路徑相匹配。其次，透過有針對性的真實世界研究和註冊登記，加強證據基礎，以證明手術效率和以患者為中心的療效，從而支持醫療系統採用和核准。第三，投資於靈活的分銷模式，將與關鍵客戶的直接互動與分銷商夥伴關係相結合，以確保覆蓋醫院、門診手術中心和診所。

採用穩健的混合調查方法，整合臨床醫師見解、法規環境和供應鏈分析，以得出可操作的結論。

本分析的調查方法融合了定性和定量方法，旨在全面了解整個疝氣修補器市場。主要研究包括對外科醫生、採購主管和分銷合作夥伴進行結構化訪談，以了解器械性能的考量因素、推廣應用障礙和培訓需求。次要研究則整合了同儕審查的臨床文獻、監管指南和公共採購框架，以分析臨床趨勢和政策影響。

整合關鍵的臨床、商業性和供應鏈挑戰，從而為疝氣修補器市場的永續領導地位指明方向

總之，疝氣修補器領域正處於一個轉折點，不斷發展的臨床實踐、材料創新和重塑的商業模式在此交匯融合。這些器械的未來取決於製造商如何有效地回應外科醫生的偏好，如何使材料和產品類型與臨床應用案例相匹配，以及如何投資於能夠切實提高手術效率和改善患者預後的證據。供應鏈的韌性和適應性分銷策略也將發揮至關重要的作用，尤其是在貿易政策變化影響材料採購和成本動態的情況下。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 疝氣手術市場（按類型分類）

  • 不吸水釘
  • 吸收性塔克
  • 免洗釘槍
  • 可重複使用的標記器

9. 依材料類型分類的疝氣修補器市場

  • 聚合物
  • 鈦

第10章 疝氣修補器市場（依產品類型分類）

  • 一次性
  • 可重複使用的

第11章 疝氣修補器市場按應用領域分類

  • 切口疝
  • 腹股溝疝氣
  • 臍疝氣
  • 腹壁疝

第12章 疝氣修補器市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 醫院

第13章 疝氣修補器市場依通路分類

  • 直銷
  • 經銷商

第14章 疝氣修補器市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 疝氣塔克市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國疝氣塔克市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國疝氣修補術市場

第18章：中國的疝氣手術市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Atrium Medical Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Cook Medical LLC
  • Ethicon, Inc.
  • Herniamesh Srl
  • LifeCell Corporation
  • Medtronic plc
  • Via Surgical Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-0A380695183F

The Hernia Tacker Market was valued at USD 162.21 million in 2025 and is projected to grow to USD 177.27 million in 2026, with a CAGR of 6.54%, reaching USD 252.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 162.21 million
Estimated Year [2026] USD 177.27 million
Forecast Year [2032] USD 252.84 million
CAGR (%) 6.54%

Concise framing of clinical utility, procurement considerations, and strategic relevance of hernia tackers across contemporary surgical environments

The evolution of surgical fixation devices requires an executive-level synthesis that balances clinical utility, procurement realities, and supply chain resilience. This introduction frames the hernia tacker landscape by outlining the device's role in modern hernia repair workflows, the procedural contexts in which it is adopted, and the intersection of clinical outcomes with device ergonomics and material choices. Closer inspection reveals that the hernia tacker is not a single-purpose commodity but a configurable tool that varies by material composition, disposability, and compatibility with minimally invasive techniques.

Transitioning from description to strategic relevance, the introduction emphasizes how stakeholders across hospitals, ambulatory surgical centers, and clinics evaluate these devices through lenses of procedure throughput, surgeon preference, and cost-of-care. It also highlights the importance of product training and clinical evidence in shaping adoption curves. Finally, the introduction establishes the analytical approach used throughout the report: integrating clinical practice trends, procurement patterns, and regulatory dynamics to present a cohesive view that supports senior leaders in making informed, actionable choices.

Rapid clinical, material, and procurement shifts are reconfiguring how surgical teams and suppliers prioritize device performance and long-term outcomes

The hernia tacker landscape is experiencing transformative shifts driven by clinical practice evolution, material science advances, and changing care delivery models. Over the past several years, minimally invasive techniques and enhanced recovery protocols have increased demand for devices that streamline fixation while reducing operative time and postoperative complications. Concurrently, innovations in polymer formulations and titanium alloys have expanded design possibilities, enabling lighter, more biocompatible fixation elements that align with surgeons' ergonomic preferences.

In addition to technological change, procurement and distribution models are shifting toward value-based purchasing and broader use of ambulatory surgical centers. These dynamics are redefining how device suppliers engage with health systems and surgical teams, prompting manufacturers to invest in outcome-focused clinical evidence and training programs. Regulatory focus on device traceability and post-market surveillance is also intensifying, which in turn affects product development timelines and labeling strategies. Taken together, these trends signal a market that is moving from commodity-driven transactions toward collaborative partnerships centered on clinical outcomes, cost-efficiency, and long-term device performance.

Evolving tariff dynamics in 2025 are intensifying supply chain resilience needs and reshaping procurement strategies for surgical device stakeholders

The cumulative effect of tariff adjustments and trade policy developments in 2025 has introduced additional layers of operational complexity for manufacturers, distributors, and health system procurement teams. Shifts in tariff structures affect raw material sourcing choices, particularly for devices that incorporate high-value metals like titanium or specialized medical-grade polymers. As a result, supply chain planners must now balance cost pressures against the clinical imperative for consistent device quality and regulatory compliance.

These changes have also reinforced the importance of diversified sourcing strategies and localized manufacturing where feasible. Organizations that previously relied on single-region supply chains now evaluate dual-sourcing options or regional inventory buffering to mitigate exposure to trade disruptions. Meanwhile, procurement teams are renegotiating supplier agreements to include contingencies for tariff-driven cost adjustments and to preserve long-term clinical relationships. Ultimately, the tariff environment of 2025 has sharpened the focus on supply chain resilience, regulatory alignment, and transparent cost modeling as prerequisites for sustained device availability and predictable procurement budgeting.

Segment-driven insight that connects clinical use cases, product form factors, distribution pathways, and material selection to practical commercialization choices

A nuanced understanding of segmentation informs product design, market access tactics, and clinical engagement strategies. Based on Application, market is studied across Incisional Hernia, Inguinal Hernia, Umbilical Hernia, and Ventral Hernia, and each application presents distinct fixation challenges and clinical priorities that influence device selection and surgeon preference. Based on Product Type, market is studied across Disposable and Reusable options, creating divergent value propositions tied to unit economics, sterilization infrastructure, and infection control protocols. Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals, which differ in procedural volume, purchasing authority, and care delivery models, affecting adoption pathways and logistics.

Based on Distribution Channel, market is studied across Direct Sales and Distributor frameworks, which determine the nature of customer relationships, post-sale support, and training programs that accompany device deployment. Based on Material Type, market is studied across Polymer and Titanium solutions, and material selection drives trade-offs among cost, radiopacity, biocompatibility, and long-term implant behavior. Integrating these segmentation perspectives enables stakeholders to map product attributes to clinical use cases, prioritize investment in evidence generation, and align commercial models with the operational realities of distinct care settings.

Geographic distinctions in procurement, clinical practice, and infrastructure that determine differentiated strategic approaches across global regions

Regional dynamics influence regulatory pathways, purchasing behaviors, and clinical practice patterns, creating differentiated opportunities and constraints for device manufacturers and suppliers. Americas markets often emphasize streamlined procurement cycles, higher utilization of ambulatory surgical centers, and a strong focus on evidence demonstrating reductions in procedure time and post-operative complications. Europe, Middle East & Africa exhibit heterogeneity in regulatory frameworks and hospital procurement processes, which elevates the importance of localized clinical data and targeted reimbursement strategies. Asia-Pacific demonstrates rapid adoption of minimally invasive techniques alongside varied hospital infrastructure, creating demand for both cost-effective disposable options and durable reusable systems depending on local clinical economics.

These regional profiles inform go-to-market strategies, distribution footprint planning, and clinical education investments. For instance, engagement that prioritizes ambulatory surgical center workflows will resonate more strongly in markets that are shifting procedures out of inpatient settings, whereas regions with centralized hospital procurement require deeper health economics and outcomes research to support adoption. By aligning product positioning with the specific characteristics of the Americas, Europe, Middle East & Africa, and Asia-Pacific, organizations can better allocate resources and design regionally appropriate value propositions.

Competitive landscape analysis emphasizing clinical support, product differentiation, and channel effectiveness as drivers of sustainable advantage

Competitive dynamics in the hernia tacker space are shaped by a blend of clinical evidence, technology differentiation, and commercial execution. Leading companies compete on the merits of device ergonomics, material science, and the depth of clinical support they provide to surgical teams. Some firms emphasize disposability and single-use convenience to meet infection control and throughput demands, while others focus on reusable platforms that minimize per-case costs in high-volume centers. In many cases, competitive advantage derives from complementary services, including surgeon training programs, procedural documentation, and responsive distribution networks.

In addition, intellectual property surrounding novel fixation mechanisms and coating technologies plays a role in defining competitive boundaries. Companies that invest early in post-market surveillance and long-term outcomes studies tend to build stronger clinical credibility, which supports premium positioning and inclusion in standardized hospital formularies. The interplay of pricing strategies, channel partnerships, and targeted clinical engagement ultimately determines which companies can sustain growth while meeting increasingly stringent regulatory and procurement expectations.

Practical and strategic actions for executives to strengthen clinical adoption, supply chain resilience, and value-focused commercialization in device portfolios

Industry leaders should prioritize a set of tactical and strategic initiatives to convert insights into measurable outcomes. First, align product portfolios to clinical pathways by matching material and product type decisions to the specific procedural demands of incisional, inguinal, umbilical, and ventral repairs. Second, strengthen the evidence base through targeted real-world studies and registries that demonstrate comparative procedural efficiency and patient-centered outcomes, thereby supporting health system adoption and procurement approvals. Third, invest in flexible distribution models that combine direct engagement with key accounts and distributor partnerships to ensure coverage across hospitals, ambulatory surgical centers, and clinics.

Additionally, build supply chain resilience through diversified sourcing and regional inventory strategies to mitigate tariff and trade volatility. Expand surgeon training and implementation support to reduce the learning curve and enhance procedural consistency. Finally, adopt pricing frameworks that reflect total cost of care implications, enabling procurement teams to see the long-term value of device choices. Executing these recommendations will help organizations improve clinical adoption rates, reduce operational risk, and enhance the commercial durability of their product portfolios.

Robust mixed-methods research approach combining clinician insight, regulatory context, and supply chain analysis to support actionable conclusions

The research methodology underpinning this analysis integrates qualitative and quantitative approaches to produce a holistic understanding of the hernia tacker landscape. Primary research encompassed structured interviews with surgeons, procurement leaders, and distribution partners to capture practical device performance considerations, adoption barriers, and training needs. Secondary research synthesized peer-reviewed clinical literature, regulatory guidance, and publicly available procurement frameworks to contextualize clinical trends and policy influences.

Analytical methods included comparative device attribute mapping, supply chain sensitivity analysis, and segmentation-driven commercial modeling to evaluate how product characteristics align with different clinical settings and distribution channels. Triangulation across data sources ensured that conclusions reflect both frontline clinical experience and systemic market observations. Throughout the process, attention was paid to regulatory compliance, real-world usability, and the operational constraints that influence procurement decisions, yielding findings that are both actionable and grounded in contemporary practice.

Synthesis of clinical, commercial, and supply chain imperatives that define pathways to sustainable leadership in the hernia tacker market

In conclusion, the hernia tacker domain is at an inflection point where clinical practice evolution, material innovation, and commercial model reconfiguration converge. The device's trajectory will be determined by how effectively manufacturers respond to surgeon preferences, align materials and product types with clinical use cases, and invest in evidence that demonstrates tangible improvements in procedural efficiency and patient outcomes. Supply chain resilience and adaptive distribution strategies will also play critical roles, particularly in the face of trade policy shifts that affect material sourcing and cost dynamics.

Strategic success requires balancing near-term operational priorities with longer-term investments in clinical data and product differentiation. Organizations that integrate segmented market understanding with targeted regional strategies and close collaboration with surgical teams will be best positioned to convert technical capability into clinical adoption and sustainable commercial performance. This synthesis underscores the importance of deliberate, evidence-based decision-making for stakeholders seeking to lead in the hernia tacker space.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hernia Tacker Market, by Type

  • 8.1. Non-Absorbable Tackers
  • 8.2. Absorbable Tackers
  • 8.3. Disposable Tackers
  • 8.4. Reusable Tackers

9. Hernia Tacker Market, by Material Type

  • 9.1. Polymer
  • 9.2. Titanium

10. Hernia Tacker Market, by Product Type

  • 10.1. Disposable
  • 10.2. Reusable

11. Hernia Tacker Market, by Application

  • 11.1. Incisional Hernia
  • 11.2. Inguinal Hernia
  • 11.3. Umbilical Hernia
  • 11.4. Ventral Hernia

12. Hernia Tacker Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Hernia Tacker Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributor

14. Hernia Tacker Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Hernia Tacker Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Hernia Tacker Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Hernia Tacker Market

18. China Hernia Tacker Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Atrium Medical Corporation
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Cook Medical LLC
  • 19.9. Ethicon, Inc.
  • 19.10. Herniamesh S.r.l.
  • 19.11. LifeCell Corporation
  • 19.12. Medtronic plc
  • 19.13. Via Surgical Ltd.
  • 19.14. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERNIA TACKER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERNIA TACKER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERNIA TACKER MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERNIA TACKER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERNIA TACKER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERNIA TACKER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HERNIA TACKER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HERNIA TACKER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERNIA TACKER MARKET SIZE, BY NON-ABSORBABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERNIA TACKER MARKET SIZE, BY NON-ABSORBABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERNIA TACKER MARKET SIZE, BY NON-ABSORBABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERNIA TACKER MARKET SIZE, BY ABSORBABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERNIA TACKER MARKET SIZE, BY ABSORBABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERNIA TACKER MARKET SIZE, BY ABSORBABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE TACKERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE TACKERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE TACKERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERNIA TACKER MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERNIA TACKER MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERNIA TACKER MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERNIA TACKER MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERNIA TACKER MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERNIA TACKER MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERNIA TACKER MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERNIA TACKER MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERNIA TACKER MARKET SIZE, BY INCISIONAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERNIA TACKER MARKET SIZE, BY INCISIONAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERNIA TACKER MARKET SIZE, BY INCISIONAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERNIA TACKER MARKET SIZE, BY INGUINAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERNIA TACKER MARKET SIZE, BY INGUINAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERNIA TACKER MARKET SIZE, BY INGUINAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERNIA TACKER MARKET SIZE, BY UMBILICAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERNIA TACKER MARKET SIZE, BY UMBILICAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERNIA TACKER MARKET SIZE, BY UMBILICAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERNIA TACKER MARKET SIZE, BY VENTRAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERNIA TACKER MARKET SIZE, BY VENTRAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERNIA TACKER MARKET SIZE, BY VENTRAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERNIA TACKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERNIA TACKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERNIA TACKER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERNIA TACKER MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERNIA TACKER MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERNIA TACKER MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERNIA TACKER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERNIA TACKER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA TACKER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA TACKER MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERNIA TACKER MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERNIA TACKER MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERNIA TACKER MARKET SIZE, BY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERNIA TACKER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS HERNIA TACKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HERNIA TACKER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 124. GCC HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. G7 HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. G7 HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. NATO HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. NATO HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL HERNIA TACKER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA HERNIA TACKER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA HERNIA TACKER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA HERNIA TACKER MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA HERNIA TACKER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA HERNIA TACKER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA HERNIA TACKER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA HERNIA TACKER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)